This is the first month seeing a growth after three-month decline. Accordingly, pharmaceutical imports jumped by 14.38% to US$2.1 billion in the first 10 months of this year.The imported drug come from 28 countries, of which France ranked first with US$270.7 million (up 16.54% and accounting for 14% of total import value), trailed by India (up 11.7% to US$230.1 million) and Germany (up 19.15% to US$198.5 million).In the reviewed period, imports from the UK suffered the deepest decrease of 48.01% while Argentina enjoyed the strongest growth of 687.75%.With an average growth of two-digits, the domestic drug market is an attractive destination for foreign investors. They have cooperated with domestic partners to expand market shares since early this year.